← All Lisata Therapeutics, INC filings

Lisata Therapeutics, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
LSTA
Lisata Therapeutics, INC
10-K/A: Lisata Therapeutics Files Amended Annual Report
Lisata Therapeutics, Inc. has filed an amendment to its 2025 Form 10-K to include previously omitted Part III information regarding corporate governance, executive compensation, and security ownership.
NASDAQ
LSTA
Lisata Therapeutics, INC
10-K: Lisata Therapeutics Reports 2024 Financial Results, Provides Business Update
Lisata Therapeutics, a clinical-stage pharmaceutical company, details its financial performance for 2024 and provides an overview of its ongoing development programs.
NASDAQ
LSTA
Lisata Therapeutics, INC
10-K: Lisata Therapeutics Files 10-K Annual Report, Details Financials and Clinical Progress
Lisata Therapeutics' 10-K filing for the year ended December 31, 2023, highlights the company's financial status, clinical development programs, and regulatory landscape.